GlassScriptPhysician profile
Venus Howard
NPI 1518768159
$1,266.99
in general payments reported to CMS, 2019-2025
6 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022 · Travel and Lodging: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.62 |
| Travel and Lodging | $245.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $691.13 | 2025 | Evoke |
| Boston Scientific Corporation | $313.26 | 2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Nalu Medical, INC. | $160.08 | 2025 | Nalu Neurostimulation System |
| Aucta Pharmaceuticals, INC. | $45.88 | 2025 | Motpoly Xr |
| Vertex Pharmaceuticals Incorporated | $28.56 | 2025 | |
| Biogen, INC. | $28.08 | 2025 | Vumerity, Tysabri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Venus Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.